Evidence map›Paper›PMID 20454510›Full record

ArticleNeoplasia (New York, N.Y.)2010

Comparison of tumor and microenvironment secretomes in plasma and in platelets during prostate cancer growth in a xenograft model.

Bethany A Kerr, Ranko Miocinovic, Armine K Smith, Eric A Klein, Tatiana V Byzova

Abstract readComparative Study
In one paragraph

Article in Neoplasia (New York, N.Y.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Platelets as messengers of early-stage cancer.Cancer metastasis reviews · 2021
    Review
  8. Blood Platelets as an Important but Underrated Circulating Source of TGFβ.International journal of molecular sciences · 2021
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. The interconnectedness of cancer cell signaling.Neoplasia (New York, N.Y.) · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bethany A KerrDepartment of Molecular Cardiology, Joseph J. Jacobs Center for Thrombosis and Vascular Biology, Lerner Research Institute, Cleveland, OH, USA.
Ranko Miocinovic
Armine K Smith
Eric A Klein
Tatiana V Byzova

Funding

Regulation of Integrins in Neovasculature DevelopmentR01HL071625 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI BYZOVA, TATIANA V · 2003 to 2021
$7.3M
Role of Integrins and bone matrix in prostate cancerR01CA126847 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI BYZOVA, TATIANA V · 2007 to 2011
$1.4M
Molecular Mechanisms of Prostate Cancer Induced Bone RemodelingF32CA142133 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI KERR, BETHANY AMBER · 2010 to 2013
$116k
NCI NIH HHS CA126847NCI NIH HHS F32 CA142133NCI NIH HHS R01 CA126847NHLBI NIH HHS R01 HL071625
6 · The paper itself

Abstract

To survive and metastasize, tumors interact with surrounding tissues by secreting growth factors and cytokines. In return, surrounding host tissues respond by changing their secretome. Numerous factors theoretically function as therapeutic targets or biomarkers of cancer growth and metastatic risk. However, it is unclear if these factors are tumor-derived or actually represent the host defense. To analyze the concentrations of tumor- and microenvironment-derived factors associated with neoplastic growth, we used ELISA-based arrays specific for murine or human proteins to establish a profile of tumor- or host-derived factors circulating in the plasma or within the platelets upon human tumor implantation into mice. Many factors characterized as tumor-derived were actually secreted by host tissues. This study uncovered the origin of various cytokines and revealed their circulation methods. We found that tumor-produced cytokines are predominantly sequestered in platelets. Sequestered proteins are protected from degradation and, thus, may be functional at metastatic sites. These findings identify tumor-specific targets for the detection and prevention of tumor growth and metastasis. As predicted by our model, monocyte chemotactic protein 1 and tumor necrosis factor alpha may be biomarkers for human cancers. Thus, our study identified several potential biomarkers that might be predictive of prostate cancer.

Indexed as

AnimalsBiomarkers, TumorBlood PlateletsChemokine CCL2CytokinesEnzyme-Linked Immunosorbent AssayHumansMaleMiceMice, Inbred NODProstatic NeoplasmsProtein Array AnalysisTumor Necrosis Factor-alphaBiomarkers, TumorChemokine CCL2CytokinesTumor Necrosis Factor-alpha

Identifiers

PMID20454510
PMCPMC2864476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.